Cancer and HIV infection

Clinical Oncology

Volumn 9, Issue 6, 1997, Pages 365-380

  Cottrill, C P ^a   Bottomley, D M ^b   Phillips, R H ^c  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTHRACYCLINE; BLEOMYCIN; CHORIONIC GONADOTROPIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GANCICLOVIR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIPOSOME; MACROGOL; METHOTREXATE; MITOMYCIN; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALOPECIA; ANUS CANCER; BLOOD TOXICITY; BOLUS INJECTION; CANCER CHEMOTHERAPY; CLINICAL RESEARCH; CRYOTHERAPY; DEMOGRAPHY; DOSIMETRY; DRUG TOXICITY; HEALTH BEHAVIOR; HEART FAILURE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSENSITIVITY REACTION; INTRALESIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LUNG TOXICITY; NEUTROPENIA; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PATHOLOGY; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RETINITIS; REVIEW; SEPSIS; TREATMENT INDICATION; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0031445003     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(97)80129-X     Document Type: Review

References (180)

1. Peters BS, Beck FJ, Coleman DG, et al. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ 1991;302:203-7.
2. Centers for Disease Control. Revision of the CDC Surveillance Case Definition for acquired immunodeficiency syndrome. JAMA 1987;258:1143-9.
3. Rabkin CS, Biggars RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficiency virus. Int J Cancer 1991;47:692-6.
4. Beral V, Peterman TA, Berkelman RL, et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990;335:123-8.
5. Casabona J, Melbyc M, Biggar RJ, et al. Kaposi's sarcoma and non-Hodgkin's lymphoma in European AIDS cases. No excess risk of Kaposi's sarcoma in Mediterranean countries. Int J Cncer 1991;47:49-53.
6. Ziegler JL, Drew WL, Miner RC, et al. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet 1982;ii:631-3.
7. Beral V, Peterman TA, Berkelman RL, et al. AIDS-associated non-Hodgkin lymphoma. Lancet 1991;337:805-9.
8. Biggar RJ, Rabkin CS. The epidemiology of acquired immunodeficiency syndrome-related lymphomas. Curr Opin Oncol 1992;4:883-93.
9. Serraino D, Salamina G, Franceschi S, et al. The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organisation European Region. Br J Cancer 1992;66:912-6.
10. Roithmann S, Toledano M, Tourani JM, et al. HIV-associated non-Hodgkin's lymphomas: clinical characteristics and outcome. The experience of the French Registry of HIV-Associated Tumors. Ann Oncol 1991;2:289-95.
11. Pluda JM, Venzon DJ, Tosato G, et al. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 1993;11:1099-107.
12. Moore RD, Kessler H, Richman DD, et al. Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine. JAMA 1991;265:2208-11.
13. Wilkes MS, Fortin AH, Felix JC, et al. Value of necropsy in acquired immunodeficiency syndrome. Lancet 1988;ii:85-8.
14. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(RR-17):1-19.
15. Bradbeer C. Is infection with HIV a risk factor for cervical intraepithelial neoplasia? Lancet 1987;ii:1277-8.
16. Provencher D, Valme B, Averette HE, et al. HIV status and positive Papanicolaou screening: identification of a high risk population. Gynecol Oncol 1988;31:184-8.
17. Schrager LK, Friedland GH, Maude D, et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1989;2:570-5.
18. Henry MJ, Stanley MW, Cruikshank S, et al. Association of human immunodeficiency virus induced immunosuppression with human papilloma virus infection and cervical intraepithelial neoplasia. Am J Obstet Gynecol 1989;160:352-3.
19. Maiman M, Fruchter RG, Serur E, et al. Human immunodeficiency virus infection and cervical neoplasia. Gynecol Oncol 1990;38:377-82.
20. Mandelblatt JS, Fahs M, Garibaldi K, et al. Association between HIV infection and cervical ncoplasia: implications for clinical care of women at risk for both conditions. AIDS 1992;6:173-8.
21. Johnstone FD, McGoogan E, Smart GE, et al. A population-based, controlled study of the relation between HIV infection and cervical neoplasia. Br J Obstet Gynaecol 1994;101:986-91.
22. Wright TC, Ellerbrock TV, Chiasson MA, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7.
23. Klevens RM, Fleming PL, Mays MA, et al. Characteristics of women with AIDS and invasive cervical cancer. Obstet Gynecol 1996;88:269-73.
24. Biggar RJ, Burnett W, Mikl J, et al. Cancer among New York men at risk of acquired immunodeficiency syndrome. Int J Cancer 1989;43:979-85.
25. Reynolds P, Saunders LD, Laycfsky ME, et al. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987. Am J Epidemiol 1993;137:19-30.
26. Hessol NA, Katz MH, Liu JY, et al. Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med 1992;117:309-11.
27. Tirelli U, Errante D, Dolcetti R, et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologie features of 114 patients from the Italian Co-operative Group on AIDS and tumors. J Clin Oncol 1995;13:1758-67.
28. Andrieu JM, Roithmann S, Tourani JM, et al. Hodgkin's disease during HIV-1 infection: the French Registry experience. Ann Oncol 1993;4:635-41.
29. Garnier G, Taillan B. HIV-associated Hodgkin's disease [letter]. Ann Intern Med 1991;115:233.
30. Melbye M, Cote TR, Kessler L, et al. High incidence of anal cancer among AIDS patients. Lancet 1994;343:636-9.
31. Daling JR, Wiess NS, Klopfenstein LL, et al. Correlates of homosexual behavior and the incidence of anal cancer, JAMA 1982;247:1988-90.
32. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987;317:973-7.
33. Law CL, Qassim M, Thompson CH, et al. Factors associated with clinical and sub-clinical anal human papillomavirus infection in homosexual men. Genitourin Med 1991;67:92-8.
34. Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994;8:283-95.
35. Critchlow CW, Surawicz CM, Holmes KK, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995;9:1255-62.
36. Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS 1993;7:43-9.
37. Kaposi M. Idiopathic multiples pigmentsarcom der haut. Arch Dermatol Syph 1872;4:265-74.
38. Accuni S, Ruco LP, Monardo F, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol 1994;173:23-31.
39. Beral V, Bull D, Darby S, et al. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet 1992;339:632-5.
40. Marmor M, Friedman-Kien AE, Laubenstein L, et al. Risk factors for Kaposi's sarcoma in homosexual men. Lancet 1982;ii:1083-7.
41. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
42. Huang YQ, Li JJ, Kaplan MH, et al. Human herpes-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995;345:759-61.
43. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995;345:761-2.
44. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995;332:1181-5.
45. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
46. Haang YQ, Li JJ, Poiesz BJ, et al. Detection of the herpesvirus-like DNA sequences in matched specimens of semen and blood from patients with AIDS-related Kaposi's sarcoma by polymerase chain reaction in situ hybridisation. Am J Pathol 1997;150:147-53.
47. Ensoli B, Barillari G, Gallo RC. Pathogenesis of AIDS-associated Kaposi's sarcoma. Hematol Oncol Clin North Am 1991;5:281-95.
48. Ensoli B, Barillari G, Salahuddin SZ, et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990;345:84-6.
49. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 1994;371:674-80.
50. Vogen J, Hinrichs SH, Reynolds RK, et al. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988;335:606-11.
51. Friedman SL, Wright TL, Altman DF. Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology 1985;89:102-8.
52. Barrison IG, Foster S, Harris JW, et al. Upper gastro-intestinal Kaposi's sarcoma in patients positive for HIV antibody without cutaneous disease. BMJ 1988;296:92-3.
53. Laine L, Politoske EJ, Gill P. Protein-losing enteropathy in acquired immunodeficiency syndrome due to intestinal Kaposi's sarcoma. Arch Intern Med 1987;147:1174-5.
54. Schofer H, Ochsendorf FR, Hochscheid I, et al. Facial Kaposi's sarcoma. Palliative treatment with cryotherapy, intralesional chemotherapy, low-dose roentgen therapy and camouflage. Hautarzt 1991;42:492-8.
55. Tappero JW, Berger TG, Kaplan LD, et al. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a Phase II trial. J AIDS 1991;4:839-46.
56. Newman S. Treatment of epidemic Kaposi's sarcoma with intralesional vinblastine injection. Proc ASCO 1988; 7:5 [abstract no 19].
57. Epstein JB. Treatment of oral Kaposi's sarcoma with intralesional vinblastine. Cancer 1993;71:1722-5.
58. Sulis E, Floris C, Sulis ML, et al. Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma. Eur J Cancer Clin Oncol 1989;25:759-61.
59. Berson AM, Quivey JM, Harris JW, et al. Radiation therapy for AIDS-related Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1990;19:569-75.
60. Chak LY, Gill PS, Levine AM, et al. Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Clin Oncol 1988;6:863-7.
61. de Wit R, Smit WG, Veerhof KH, et al. Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy. Radiother Oncol 1990;19:131-6.
62. Cooper JS, Steinfeld AD, Lerch I. Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1991;20:419-22.
63. Cooper JS, Steinfeld AD, Lerch I. The prognostic significance of residual pigmentation following radiotherapy of epidemic Kaposi's sarcoma. J Clin Oncol 1989;7:619-21
64. Spittle MF. A simple and effective treatment for AIDS related Kaposi's sarcoma. BMJ 1987;295:248-9.
65. Selzer KJ, Griffen TW. A randomised trial of radiation therapy for AIDS-associated Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1993;27:1057-61.
66. Watkins EB, Findlay P, Gelmann E, et al. Enhanced mucosal reactions in AIDS patients receiving oropharyngeal irradiation. Int J Radiat Oncol Biol Phys 1987;13:1403-8.
67. Vallis KA. Glutathione deficiency and radiosensitivity in AIDS patients. Lancet 1991;337:918-9.
68. Meyer JL. Whole-lung irradiation for Kaposi's sarcoma. Am J Clin Oncol 1993;16:372-6.
69. Brunt AM, Phillips RH. Strontium-90 for conjunctival AIDS-related Kaposi's sarcoma: a first case report. Clin Oncol 1990;3:118-9.
70. de Wit R, Riess P, Bakker PJ, et al. Lack of activity of zidovudine in AIDS-associated Kaposi's sarcoma. AIDS 1989;3:847-50.
71. Lane HC, Falloon J, Walker RE, et al. Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi's sarcoma, Ann Intern Med 1989;111:41-50.
72. Scadden DT, Zon LI, Groopman JE. Pathophysiology and management of HIV-associated hematologic disorders. Blood 1989;74:1455-63.
73. Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 1989;7:1201-7.
74. Krown SE, Real FX, Cunningham-Rundles S, et al. Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 1983;308:1071-6.
75. Krown SE. Interferon and other biologic agents for the treatment of Kaposi's sarcoma. Hematol Oncol Clin North Am 1991;5:311-22.
76. Volberding PA, Mitsuyasu RT, Golando JF, et al. Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A). Cancer 1987;59:620-25.
77. Rozenbaum W, Gharakhanian S, Navarette M-S, et al. Long-term follow-up of 120 patients with AIDS-related Kaposi's sarcoma treated with interferon alpha-2A. J Invest Dermatol 1990;95:161S-5S.
78. Gelmann EP, Preble OT, Steis R, et al. Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. Am J Med 1985;78:737-41.
79. Krown SE, Real FX, Vadhan-Raj S, et al. Kaposi's sarcoma and the acquired immune deficiency syndrome. Treatment with recombinant interferon alpha and analysis of prognostic factors. Cancer 1986;57:1662-5.
80. Safai B, Bason M, Friedman-Birnbaum R, et al. Interferon in the treatment of AIDS-associated Kaposi's sarcoma: the American experience. J Invest Dermatol 1990;95:166S-9S.
81. Kovacs JA, Deyton L, Davey R, et al. Combined zidovudine and interferon-alpha therapy in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;111:280-7.
82. Krown SE, Gold JW, Niedzwiecki D, et al. Interferon-alpha with zidovudine: safety, tolerance, clinical and virologic effects in patients with Kaposi's sarcoma associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990;112:812-21.
83. Mintzer DM, Real FX, Jovino L, et al. Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:200-2.
84. Volberding PA, Abrams DI, Conant M, et al. Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med 1985;103:335-8.
85. Lassoued K, Clauvel JP, Katlama C, et al. Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin in a single agent. Cancer 1990;66:1869-72.
86. Caumes E, Guermonprez G, Katlama C, et al. AIDS-associated mucocutaneous Kaposi's sarcoma treated with bleomycin. AIDS 1992;6:1483-7.
87. Remick SC, Reddy M, Herman D, et al. Continuous infusion bloemycin in AIDS-related Kaposi's sarcoma. J Clin Oncol 1994;12:1130-6.
88. Denton AS, Simpson JK, Hallam M, et al. Effects on pulmonary function of two regimens of chemotherapy for AIDS related Kaposi's sarcoma. Clin Oncol 1996;8:48-50.
89. Laubenstein LJ, Krigel RL, Odajnyk CM, et al. Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin and vinblastine. J Clin Oncol 1984;1115-20.
90. Bakker PJM, Danner SA, Lange JMA, et al. Etoposide for epidemic Kaposi's sarcoma: a Phase II study. Eur J Cancer Clin Oncol 1988;6:1047-8.
91. Paredes J, Kahn JO, Tong WP, et al. Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection: a Phase I multicentre trial of the AIDS Clinical Trials Group. J AIDS Hum Retrovirol 1995;9:138-44.
92. Schwartsmann G, Sprinz E, Kronfeld M, et al. Phase II study of tenoposide in patients with AIDS-related Kaposi's sarcoma. Eur J Cancer 1991;27:1637-9.
93. Gill PS, Rarick MU, McCutchan JA, et al. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomised trial. Am J Med 1991;90:427-33.
94. Fischl MA, Krown SE, O'Boyle KP, et al. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. J AIDS 1993;6:259-64.
95. Shepherd FA, Burkes RL, Paul KE, et al. A Phase II study of 4′-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS. AIDS 1991;5:305-9.
96. Gill PS, Espina BM, Muggia F, et al. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 1995;13:996-1003.
97. Northfelt DW, Martin FJ, Working P, et al. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localisation, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 1996;36:55-63.
98. Present CA, Scolaro M, Kennedy P, et al. Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma. Lancet 1993;341:1242-3.
99. Money-Kyrle JP, Bates F, Ready J, et al. Liposomal daunorubicin in advanced Kaposi's sarcoma: a Phase II study. Clin Oncol 1993;5:367-71.
100. Goebel FD, Goldstein D, Goos M, et al. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. Br J Cancer 1996;73:989-94.
101. Harrison M, Tomlinson D, Stewart S. Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma. J Clin Oncol 1995;13:914-20.
102. Gill PS, Wernz J, Scadden DT, et al. A randomized trial of liposomal daunorubicin (DX) vs. adriamycin, bleomycin and vincristine (ABV) in 232 patients with advanced AIDS-related Kaposi's sarcoma [abstract]. Proc Annu Meet Am Assoc Cancer Res 1995;14:A830.
103. Gill PS, Rarick M, Bernstein-Singer M, et al. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 1990;13:315-9.
104. Gompels MM, Hill A, Jenkins P, et al. Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS 1992;6:1175-80.
105. Lipman MS, Swaden LS, Sabin CA, et al. Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS 1993;7:592-3.
106. Gill PS, Miles SA, Mitsuyasu RT, et al. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy and zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1994;8:1695-9.
107. Mitsuyasu R, Gill PS, Paredes J, et al. Combination chemotherapy, adriamycin, bleomycin, vincristine (ABV) with dideoxyinosine (ddl) or dideoxycytidine (ddC) in advanced AIDS-related Kaposi's sarcoma (ACTG 163) [abstract]. Proc Annu Meet Am Assoc Cancer Res 1995;14:A822.
108. Fife K, Bower M. Recent insights into the pathogenesis of Kaposi's sarcoma. Br J Cancer 1996;73:1317-22.
109. Lunardi-Iskandar Y, Bryant JL, Zeman RA, et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995;375:64-8.
110. Samaniego F, Bryant J, Zeman R, et al. Human chorionic gonadrotrophin (hCG) prevents development of Kaposi's sarcoma (AIDS KS-Yl) tumours by inducing apoptosis. AIDS Res Hum Retrovir 1995;11:S76.
111. Harris PJ. Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotrophin. Lancet 1995;346:118-9.
112. Bower M, Fife K, Nelson M, et al. Human chorionic gonadotrophin for AIDS-related Kaposi's sarcoma. Lancet 1995;346:642.
113. Gill PS, Lunardi-Ishkandar Y, Louie S, et al. The effects of preparations of human chorionic gonadotrophins on AIDS-related Kaposi's sarcoma. N Engl J Med 1996;335:1261-9.
114. Penn I. Tumors of the immunocompromised patient. Annu Rev Med 1988;39:63-73.
115. Zeigler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. N Engl J Med 1984;311:565-70.
116. Knowles DM, Chamulak GA, Subar M, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988;108:744-53.
117. Kaplan LD, Abrams DT, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989;261:719-24.
118. Ioachim HL, Dorsett B, Cronin W, et al. Acquired immunodeficiency syndrome-associated lymphomas. Hum Pathol 1991;22:659-71.
119. Kalter SP, Riggs SA, Cabanillas F, etal. Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males. Blood 1985;66:655-9.
120. Gill PS, Levine AM, Meyer PR, et al. Primary central nervous system lymphoma in homosexual men: clinical, immunologic and pathologic features. Am J Med 1985;78:742-8.
121. Goldstein JD, Dickson DW, Moser FG, et al. Primary central nervous system lymphoma in acquired immune deficiency syndrome. Cancer 1991;67:2756-65.
122. Pelicci P-G, Knowles DM, Airlin ZA, et al. Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immunodeficiency syndrome-related lymphoproliferative disorders. J Exp Med 1986;164:2049-76.
123. Shibata D, Brynes RX, Nathwani B, et al. Human immunodeficiency viral DNA is readily found in lymph node biopsies from seropositive individuals. Analysis of fixed tissue using the polymerase chain reaction. Am J Pathol 1989;135:697-702.
124. Beimer JJ. Malignant lymphomas associated with immunodeficiency states. Ann Clin Lab Sci 1990;20:175-91.
125. Klein G, Klein B. Evolution of tumours and the impact of molecular oncology. Nature 1985;315:190-5.
126. Birx DL, Redfield RR, Tosato G. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or related disorders. N Engl J Med 1986;314:874-9.
127. MacMahon EME, Glass JD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991;338:969-73.
128. Hamilton-Dutoit SJ, Raphael M, Audouin J, et al. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993;82:619-24.
129. Cinque P, Brytting M, Vago L, et al. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993;342:398-401.
130. Shibata D, Weiss LM, Nathwani BN, et al. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991;77:1527-33.
131. Subar M, Neri A, Knowles DM, et al. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988;72:667-71.
132. Shiramizu B, Herndier B, Meeker T, et al. Molecular and immunophenotypic characterisation of AIDS-associated, Epstein-Barr virus-negative lymphoma. J Clin Oncol 1992;10:383-9.
133. Ballerini P, Gaidano G, Gong JZ, et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 1993;81:166-76.
134. Shibata D, Weiss LM, Hernandez AM, et al. Epstein-Barr virus-associated non-Hodgkin's lymphoma in patients infected with the human immunodeficiency virus. Blood 1993;81:2102-9.
135. Raphael MM, Audouin J, Lamine M, et al. Immunophenotypic and genotypic analysis of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Correlation with histologic features in 36 cases. French Study Group of Pathology for HIV-Associated Tumors. Am J Clin Pathol 1994;101:773-82.
136. Schnittman SM, Lane HC, Higgins SE, et al. Direct polyclonal activation of human B lymphocytes by the acquired immunodeficiency syndrome virus. Science 1986;233:1084-6.
137. Kaplan LD, Shiramizu B, Herndier B, et al. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: identification of a subgroup with favourable clinical outcome. Blood 1995;85:1727-35.
138. Lowenthal DA, Straus DJ, Campbell SW, et al. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988;61:2325-37.
139. Pedersen C, Gerstoft J, Lundgren JD, et al. HIV-associated lymphoma: histopathology and association with Epstein-Barr virus genome related to clinical, immunological and prognostic features. Eur J Cancer 1991;27:1416-23.
140. Levine AM, Sullivan-Haley J, Pike MC, et al. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991;68:2466-72.
141. Cottrill CP, Young TE, Bottomley DM, et al. Prognostic factors in AIDS-related non-Hodgkin's lymphoma: the indications for intensive verus palliative therapy. Radiother Oncol 1992;24(suppl):S85.
142. Monfardini S, Vaccher E, Foa R, et al. AIDS-associated non-Hodgkin's lymphoma in Italy: intravenous drug users versus homosexual men. Ann Oncol 1990;1:203-11.
143. Gisselbrecht C, Oksenhendler E, Tirelli U, et al. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 1993;95:188-96.
144. Armitage JO, Cheson BD. Interpretation of clinical trials in diffuse large cell lymphoma. J Clin Oncol 1988;6:1335-47.
145. Gill PS, Levine AM, Krailo M, et al. AIDS-related malignant lymphoma: reults of prospective treatment trials. J Clin Oncol 1987;5:1322-8.
146. Bermudez MA, Grant KM, Rodvien R, et al. Non-Hodgkin's lymphoma in a population at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy. Am J Med 1989;86:71-6.
147. Taillan B, Barnier G, Ferrari E, et al. MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection. Acta Haematol 1993;89:10-12.
148. Levine AM, Wernz JC, Kaplan L, et al. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance treatment in AIDS-related lymphoma. A prospective multi-institutional trial. JAMA 1991;266:84-8.
149. Tirelli U, Errante D. Oksenhendler E, et al. Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor-prognosis AIDS-related lymphoma. Ann Oncol 1992;3:843-7.
150. Groopman JE, Mitsuyasu RT, DeLeo MJ, et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med 1987;317:593-8.
151. Kaplan LD, Kahn JO, Crowe S, et al. Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomised trial. J Clin Oncol 1991;6:929-40.
152. Walsh C, Wernz JC, Levine AM, et al. Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma. J AIDS 1993;6:265-71.
153. Kaplan LD, Strauss DJ, Testa MA, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 1997;336:1641-8.
154. Remick SC, McSharry JJ, Wolf BC, et al. Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma. J Clin Oncol 1993;11:1691-702.
155. Baumgartner JE, Rachlin JR, Beckstead JH, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73:206-11.
156. Formenti SC, Gill PS, Lean E, et al. Primary central nervous system lymphonia in AIDS. Results of radiation therapy. Cancer 1989;63:1101-7.
157. Dina TS, Primary central nervous system lymphoma versus toxoplasmosis in AIDS. Radiology 1991;179:823-8.
158. Forsyth PA, Yaholm J, Deangelis LM. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994;44:1473-9.
159. Chamberlain MC. Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer 1994;73:1728-30.
160. Donahue B, Cooper J, Newall J, et al. results of empiric radiotherapy for HIV associated primary CNS lymphomas. Int J Radiat Oncol Biol Phys 1989;17(suppl):223.
161. Silman FH, Sedlis A. Anogenital papilloma virus infection and neoplasia in immunosuppressed women. Obstet Gynecol Clin North Am 1987;14:537-87.
162. Fruchter RG, Maiman M, Sillman H. et al. Characteristics of cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus. Am J Obstet Gynecol 1994;171:531-7.
163. Wright TC, Moscarelli RD, Dole P, et al. Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet Gynecol 1996;87:515-9.
164. Del Priore G, Maag T, Bhattacharya M, et al. The value of cervical cytology in HIV-infected women. Gynecol Oncol 1995;56:395-8.
165. Maiman M, Fruchter RG, Serur E, et al. Recurrent cervical intraepithelial neoplasia in human immunodeficiency virus-seropositive women. Obstet Gynecol 1993;82:170-4.
166. Fruchter RG, Maiman M. Sedlis A, et al. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol 1996;87:338-44.
167. Petry KU, Scheffel D. Bode U. Cellular immunodeficiency enhances the progression of human papillomas virus-associated cervical lesions. Int J Cancer 1994;57:836-40.
168. Heard I, Bergeron C, Jeannel D, et al. Papanicolaou smears in human immunodeficiency virus-seropositive women during follow-up. Obstet Gynecol 1995;86:749-53.
169. Wright TC, Koulos j, Schnoll F, et al. Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol 1994;55:253-8.
170. Maiman M, Fruchter RG, Guy L, et al. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993;71:402-6.
171. Serrano M, Bellas C, Campo E, et al. Hodgkin's disease in patients with antibodies to human immunodeficiency virus. A study of 22 patients. Cancer 1990;65:2248-54.
172. Ree HJ, Strauchen JA, Khan AA, et al. Human immunodeficiency virus-associated Hodgkin's disease. Cancer 1991;67:1614-21.
173. Ames ED, Conjalka MS, Golberg AF, et al. Hodgkin's disease and AIDS: 23 new cases and a review of the literature. Hematol Oncol Clin North Am 1991;5:343-56.
174. Palfesky JM. Anal human papilloma virus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994;8:283-95.
175. Lorenz HP, Wilson W, Leigh B, et al. Squamous cell carcinoma of the anus and HIV infection. Dis Colon Rectum 1991;34:336-8.
176. Chadha M, Rosenblatt EA, Malamud S, et al. Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 1994;37:861-5.
177. Holland JM, Swift RS. Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 1994;193:251-54.
178. Harrison M, Tomlinson D, Stewart S. Squamous cell carcinoma of the anus in patients with AIDS. Clin Oncol 1995;7:50-1.
179. Bottomley DM, Aqel N, Selvaratnam G, et al. Epidermoid anal cancer in HIV infected patients. Clin Oncol 1996;8:319-22.
180. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCK randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348:1049-54.